Joanna L. Jankowsky
Affiliations: | Neuroscience | Baylor College of Medicine, Houston, TX |
Area:
Alzheimer's disease, learning and memoryGoogle:
"Joanna Jankowsky"Mean distance: 13.39 (cluster 32) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree - BCM Tree
Parents
Sign in to add mentor| Paul H. Patterson | grad student | 1994-1999 | Caltech |
| David R. Borchelt | post-doc | 2000-2003 | Johns Hopkins Medical School |
| Henry A. Lester | research scientist | 2003-2008 | Caltech |
Children
Sign in to add trainee| Michael Joseph Yetman | grad student | 2009- | Baylor College of Medicine |
| Emily J. Koller | grad student | 2020-2023 | Baylor College of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koller EJ, Comstock M, Bean JC, et al. (2023) Correction: Temporal and spatially controlled APP transgene expression using Cre-dependent alleles. Disease Models & Mechanisms. 16 |
| Koller EJ, Comstock M, Bean JC, et al. (2022) Temporal and spatially-controlled APP transgene expression using Cre-dependent alleles. Disease Models & Mechanisms |
| Park KW, Wood CA, Li J, et al. (2021) Gene therapy using Aβ variants for amyloid reduction. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Roy ER, Wang B, Wan YW, et al. (2020) Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. The Journal of Clinical Investigation |
| Lillehaug S, Yetman MJ, Puchades MA, et al. (2019) Brain-wide distribution of reporter expression in five transgenic tetracycline-transactivator mouse lines. Scientific Data. 6: 190028 |
| Huichalaf CH, Al-Ramahi I, Park KW, et al. (2019) Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Human Molecular Genetics |
| Chiang ACA, Fowler SW, Savjani RR, et al. (2018) Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. The Journal of Experimental Medicine |
| Jankowsky JL, Zheng H. (2017) Practical considerations for choosing a mouse model of Alzheimer's disease. Molecular Neurodegeneration. 12: 89 |
| Chiang ACA, Fowler SW, Reddy R, et al. (2017) Discrete pools of oligomeric amyloid-β track with spatial learning deficits in a mouse model of Alzheimer amyloidosis. The American Journal of Pathology |
| Verbeeck C, Carrano A, Chakrabarty P, et al. (2017) Combination of Aβ Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition. The American Journal of Pathology |